טוען...
Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation
Nowadays, minimal residual disease (MRD) is accepted as the strongest independent prognostic factor in acute lymphoblastic leukemia (ALL). It can be detected by molecular methods that use leukemia-specific or patient-specific molecular markers (fusion gene transcripts, or immunoglobulin/T-cell recep...
שמור ב:
| הוצא לאור ב: | Blood Adv |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5729622/ https://ncbi.nlm.nih.gov/pubmed/29296895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009845 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|